DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,004,000 | +37.5% | 3,888 | +35.0% | 0.06% | +37.8% |
| Q2 2022 | $730,000 | +4.6% | 2,880 | +21.0% | 0.04% | +55.2% |
| Q1 2022 | $698,000 | -26.4% | 2,380 | -17.4% | 0.03% | -14.7% |
| Q4 2021 | $948,000 | +8.1% | 2,880 | 0.0% | 0.03% | -2.9% |
| Q3 2021 | $877,000 | +4.4% | 2,880 | -8.0% | 0.04% | +6.1% |
| Q2 2021 | $840,000 | +19.1% | 3,130 | 0.0% | 0.03% | +10.0% |
| Q1 2021 | $705,000 | -26.7% | 3,130 | -27.7% | 0.03% | -30.2% |
| Q4 2020 | $962,000 | -7.5% | 4,330 | -10.4% | 0.04% | -17.3% |
| Q3 2020 | $1,040,000 | +21.8% | 4,830 | 0.0% | 0.05% | +8.3% |
| Q2 2020 | $854,000 | +97.2% | 4,830 | +54.3% | 0.05% | +29.7% |
| Q1 2020 | $433,000 | -22.3% | 3,130 | -13.8% | 0.04% | +32.1% |
| Q4 2019 | $557,000 | +29.5% | 3,630 | +21.8% | 0.03% | +16.7% |
| Q3 2019 | $430,000 | -7.3% | 2,980 | -8.3% | 0.02% | -4.0% |
| Q2 2019 | $464,000 | -12.1% | 3,250 | -18.8% | 0.02% | -13.8% |
| Q1 2019 | $528,000 | +104.7% | 4,000 | +60.0% | 0.03% | +45.0% |
| Q4 2018 | $258,000 | -5.1% | 2,500 | 0.0% | 0.02% | +53.8% |
| Q3 2018 | $272,000 | +10.1% | 2,500 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $247,000 | +0.8% | 2,500 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $245,000 | +5.6% | 2,500 | 0.0% | 0.01% | +8.3% |
| Q4 2017 | $232,000 | +8.4% | 2,500 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $214,000 | +1.4% | 2,500 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $211,000 | -1.4% | 2,500 | 0.0% | 0.01% | -7.7% |
| Q1 2017 | $214,000 | +5.9% | 2,500 | +25.0% | 0.01% | -13.3% |
| Q2 2016 | $202,000 | -5.6% | 2,000 | -20.0% | 0.02% | +15.4% |
| Q4 2014 | $214,000 | -35.7% | 2,500 | -47.9% | 0.01% | -45.8% |
| Q3 2013 | $333,000 | -73.4% | 4,800 | -75.8% | 0.02% | -78.2% |
| Q2 2013 | $1,253,000 | – | 19,800 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |